BOLERO-4: Multicenter, Open-Label, Phase Ii Study of Everolimus plus Letrozole as First-Line Therapy in Er+, Her2(-) Metastatic Breast Cancer.

AuthID
 P-00P-8Q4
8
Author(s)
Bachelot, TD
·
Saletan, S
·
Graham, AM
·
Rubini Liedke, PER
·
Azevedo, SJ
·
Sriuranpong, V
·
Cardoso, F
Tipo de Documento
Abstract
Year published
2013
Publicado
in JOURNAL OF CLINICAL ONCOLOGY, ISSN: 0732-183X
Volume: 31, Número: 15
Conference
49Th Annual Meeting of the American-Society-Of-Clinical-Oncology (Asco), Date: MAY 31-JUN 04, 2013, Location: Chicago, IL, Patrocinadores: Amer Soc Clin Oncol
Indexing
Wos®
Publication Identifiers
Wos: WOS:000335419605491
Source Identifiers
ISSN: 0732-183X
Export Publication Metadata
Lista Marked
 Adicionar à lista Marked
Info
At this moment we don't have any links to full text documens.

Um espaço para investigadores e suas Instituições

Links Úteis

Ajuda

© 2024 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service